2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lymphoma
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Prostatic Neoplasms
32
Lymphoma, Large B-Cell, Diffuse
29
Lymphoma, Follicular
15
Leukemia
15
Lymphoma, Non-Hodgkin
13
Hodgkin Disease
11
Burkitt Lymphoma
10
Leukemia, Biphenotypic, Acute
8
Neoplasm Metastasis
7
Recurrence
6
Neoplasms
6
Lymphoma, Large-Cell, Anaplastic
6
Lymphoma, B-Cell
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Hemangioma
5
Ovarian Neoplasms
4
Multiple Myeloma
4
Immunoblastic Lymphadenopathy
4
Dendritic Cell Sarcoma, Interdigitating
4
Metastatic Castration-resistant Prostate Cancer
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, T-Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, B-Cell, Marginal Zone
3
Breast Neoplasms
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neurotoxicity Syndromes
2
Interventions
Endoscopy
15
Endoscopy, Digestive System
13
Biopsy
11
Endoscopic Mucosal Resection
8
Specimen Handling
7
Radiofrequency Ablation
7
Esomeprazole
7
Gastroscopy
6
Proflavine
4
Omeprazole
4
Aspirin
4
Narrow Band Imaging
3
Diagnostic Imaging
3
Breath Tests
3
YF 476
2
Proton Pump Inhibitors
2
Photochemotherapy
2
Microscopy, Confocal
2
Metformin
2
Lansoprazole
2
Itraconazole
2
Endoscopes
2
Dexlansoprazole
2
Cryotherapy
2
Cryosurgery
2
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
2
rofecoxib
1
polyphenon E
1
plecanatide
1
omeprazole, sodium bicarbonate drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Barrett Esophagus
×
Prednisolone
×
Clear all
NCT02004782
2025-03-27
BERST
Western Sydney Local Health District
Phase 4
Withdrawn